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Abstract
Background: Numerous serologic tests are available for the diagnosis of H. pylori infection in children. Common designs of
antibody-based detection tests are ELISA and Western Blot (WB). For developing countries with limited laboratory resources
and access, ELISA would be the preferred method because of its simplicity, lower cost and speed. Although in adults ELISA
has proven to be highly accurate in diagnosing H. pylori infection; in children, it has shown variable accuracy.
Methods/Findings: We conducted a systematic review and meta-analysis to assess the accuracy of antibody-based
detection tests for the diagnosis of H. pylori infection in children. Selection criteria included participation of at least 30
children and the use of a gold standard for H. pylori diagnosis. In a comprehensive search we identified 68 studies.
Subgroup analyses were carried out by technique, immunoglobulin class, and source of test (commercial and in-house). The
results demonstrated: 1) WB tests showed high overall performance, sensitivity 91.3% (95% CI, 88.9–93.3), specificity 89%
(95% CI, 85.7–91.9), LR+ 8.2 (95% CI, 5.1–13.3), LR2 0.06 (95% CI, 0.02–0.16), DOR 158.8 (95% CI, 57.8–435.8); 2) ELISA-IgG
assays showed low sensitivity 79.2% (95% CI, 77.3–81.0) and high specificity (92.4%, 95% CI, 91.6–93.3); 3) ELISA commercial
tests varied widely in performance (test for heterogeneity p,0.0001); and 4) In-house ELISA with whole-cell antigen tests
showed the highest overall performance: sensitivity 94% (95% CI, 90.2–96.7), specificity 96.4% (95% CI, 94.2–97.9), LR+ 19.9
(95% CI, 7.9–49.8), LR2 0.08 (95% CI, 0.04–0.15) DOR 292.8 (95% CI, 101.8–841.7).
Conclusions/Significance: WB test and in-house ELISA with whole-cell antigen tests are the most reliable tests for the
diagnosis of H. pylori infection in children. Antigens obtained from local strains of the community could partially explain the
good overall accuracy of the in-house ELISA. Because of its cost and technical demands, in-house ELISA might be more
suitable for use in developing countries.
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Introducion
Helicobacter pylori infection is one of the most common bacterial
infections in humans affecting nearly 50% of the world’s
population [1,2]. H. pylori has been linked with the development
of gastritis, peptic ulcer, gastric cancer and MALT-lymphoma [3–
5]. Infection is usually acquired during childhood and is associated
with socio-demographic factors such as low socio-economic status,
poor hygiene, and crowding [6–8]. In children the diagnosis is
often difficult to establish as signs and symptoms; such as
abdominal pain, diarrhea, and occasional vomiting, are non-
specific [9–11]. H. pylori colonisation results in local and systemic
humoral response and it has been reported that, after infection,
children primarily develop an immune serologic response against
low-molecular-weight antigens [12–14].
Currently, several invasive and non-invasive diagnostic tests are
used for the detection of H. pylori infection in children
[10,11,15,16]. Invasive tests rely primarily on the identification
of H. pylori in culture, histological examination, and the rapid
urease test (RUT) [11,17,18]. Non-invasive tests include the
detection of bacterial urease activity by urea breath test (UBT),
antibody-based detection test in different fluids; and recently
antigen detection in stool [11,19–23].
Serological tests for H. pylori infection have been helpful in
epidemiological studies of prevalence, mode of transmission and
spontaneous clearance of the infection; allowing for the develop-
ment of preventive measures of infection early in life [6,7,24,25].
Antibody-based tests have been developed during the last decades.
These tests differ in a number of features: antigen composition
(e.g., different H. pylori strains); antigen source (e.g., native or
recombinant); protocols for antigen purification; class of immu-
noglobulin detected (e.g., IgG, IgA, IgM); origin of samples (e.g.,
serum, saliva, urine); and test source (i.e., commercial and in-house
test). The main advantages of antibody-based tests are their
simplicity, low cost, speed, and minimal patient discomfort. Their
performance has been critically appraised in several descriptive
reviews and textbook chapters [26–30]. Common designs of
antibody-based detection test include the enzyme-linked immu-
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The ELISA format has the advantages that many serum samples
can be tested in parallel and the process can be completely
automated. For developing countries with limited laboratory
resources and access, this test would be the preferred method.
Although ELISA has proven to be highly accurate for the
diagnosis of H. pylori infection in adults, in children it has shown
variable sensitivity and specificity [10,11,15,16,31,32]. On the
other hand, WB allows the direct visualization of antibody binding
to specific H. pylori antigens, including the virulence factors CagA
and VacA [33]. These proteins are highly immunogenic and
usually stimulate a specific IgG immune response against proteins
of 118 to 136 kDa for CagA and 89 kDa for VacA. Hence, this
test seems to be more accurate for the diagnosis of H. pylori
infection in children, and presumably could additionally distin-
guish infection with virulent strains [14,34,35].
The systemic immune response against H. pylori typically shows
a transient rise in specific IgM antibodies, followed by a rise in IgG
and IgA antibodies that persist during infection. Since IgM
antibodies against H. pylori are detected only transiently, they have
little value for the serological diagnosis of infection [27]. Therefore
diagnostic commercial and in-house tests have been developed for
detection of H. pylori-specific IgG and IgA antibodies in serum
saliva and urine. Detection of H. pylori-specific IgA and IgG
antibodies in saliva from general population has shown limited
sensitivity 80% and specificity 70% [28,36–37]. H. pylori-specific
IgG in urine has shown more sensitivity (95.5%) and specificity
(83%) [38–40]. Most IgG diagnostic tests are serum-based. Several
studies have evaluated the diagnostic value of commercial ELISA-
IgG for the detection of H. pylori infection. Two previous meta-
analyses performed in general population have been described.
The first meta-analysis (21 studies) only evaluated commercial
ELISA tests and reported an overall sensitivity and specificity of
85% and 79%, respectively [41]. The second meta-analysis (36
studies) assessed the performance of different commercial H. pylori
tests measuring IgA, IgG and IgM antibodies and reported pooled
estimates for sensitivity of 92% and for specificity of 83%. Overall
accuracy was low and considerable heterogeneity was present,
these values of sensitivity and specificity reported in the previous
meta-analysis reflect the response values mostly in adults [42].
When the performance of a diagnostic test is evaluated,
properties of the test are often described using sensitivity and
specificity. The addition of statistics such as positive and negative
likelihood ratios (LR+ and LR2) and the diagnostic odds ratio
(DOR) can help the healthcare provider determine how to interpret
the result of the test in a more clinically meaningful way for the
pediatricpatient[43–45].Hence,wecarried outa systematicreview
and meta-analysis to evaluate the performance of the different
antibody-based detection tests available for H. pylori infection in
children by determining sensitivity and specificity estimates as well
as additional accuracy values relevant to clinical practice.
Methods
Identification of studies
We searched the databases PUBMED, EMBASE, and LILACS
for references published between January 1997 and May 2007.
The search terms used included: ‘‘Helicobacter pylori’’ ‘‘Children’’,
‘‘Serological Test’’, ‘‘Antibody Detection’’, ‘‘Western Blot’’,
‘‘ELISA’’, ‘‘Specificity’’ and ‘‘Sensitivity’’. English and Spanish
references were included in the search. The final set of in-extent
review of the selected literature included cross checked references
and direct communication with the corresponding authors when
the article was not available in full length on-line.
Study eligibility and data extraction
Studies were initially selected according to the following criteria:
a) language: English or Spanish full text articles; b) diagnosis of H.
pylori: based on gold-standard (culture, histology and/or UBT); c)
study design: cross-sectional or case control; d) data collection:
prospective or retrospective; e) sample size: at least 30 participants
(15 patients and 15 controls); f) age: 0–19 year; and g) data: actual
numbers of True Positive, True Negative, False Positive and False
Negative results of the tests or predicted positive and negative
values. The articles that were finally included in the meta-analysis
were reviewed independently by two different experts and
discrepancies in the interpretation were resolved by consensus.
Data was included in an Excel database which was cross checked
for input errors. With the information available in the selected
studies, we calculated the following values: PPV, PPN, LR+,L R 2,
DOR and their corresponding 95% confidence intervals (95%,
CI). Reviews, letters to the editor, opinions and recommendations
about the diagnostic H. pylori infection in children were excluded.
Assessment of Study Quality
We assessed the quality of the studies using the following criteria,
which have been suggested as being important for diagnostic studies
[46]; a) was there a comparison of the antibody-based detection test
with an appropriate reference standard? (i.e. the ELISA and WB
detection tests did not form part of the reference standard); b) was
the antibody-based detection test result performed and recorded by
technicians who were unaware (i.e. blinded) of the results of the
reference standard?; c) did the whole sample or a randomly selected
subset of the sample received verification using the reference
standard?; d) did the study prospectively recruit consecutive
children suspected of having H. pylori infection? (i.e. cross-sectional
versus case control design).
Outcomes of interest
We determined sensitivity (proportion of positive test result
among those with the infection) and specificity (proportion of
negative test results among those without the infection). In addition,
we calculated LR’s statistics considered to provide guidance to
clinicians. LR+ measures how many times a positive test is more
likely found in infected versus non-infected children, whereas LR2
measures how many times a negative result is more likely found in
infected versus non-infected children. A higher value of the LR+
confirms the presence of the infection; and a lower LR2 excludes
the presence of the infection, in contrast to the positive and negative
predicted values (PPV & NPV), the LR’s allow the determination of
the accuracy of the test in populations with different prevalence of
the infection. Furthermore, LR+ and LR2 are combined to obtain
a new factor, DOR that describes the ratio of the odds of a positive
result test in a child with infection compared with a positive test in a
child without infection. The value of a DOR ranges from 0 to
infinity, with higher values indicating better discriminatory
performance or higher accuracy of the test [43–45].
Meta-analysis
We used standard methods recommended for meta-analysis of
diagnostic tests studies [47,48]. Estimates of sensitivity and
specificity from individual studies and their exact 95% confidence
intervals were obtained and forest plots made using MetaDiSc
Beta-1.4 software (Universidad Complutense, Madrid Espan ˜a).
Heterogeneity. In meta-analysis of diagnostic studies
heterogeneity refers to the degree of variability in accuracy
estimates across studies. An exploration of the reasons for
heterogeneity is an important goal of a meta-analysis [49].
H. pylori Diagnosis in Children
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test accuracy are difficult to interpret. Statistical significance of
heterogeneity among studies was calculated using the chi-square
test. We further investigated reasons for heterogeneity using
stratified (subgroup) analyses.
Summary Receiver Operating Characteristic (SROC)
Curve. We summarized the joint distribution of true positive
and true negative rates in a SROC curve. The SROC curve is
used for the evaluation of diagnostic tests and represents the
relationship between true positive and negative rates considering
the varying diagnostic thresholds among studies. Each data point
in the SROC space indicates the sensitivity and specificity
estimates of a single study. A regression curve is fitted through
the distribution of the paired sensitivity and specificity values. The
area under the curve (AUC) represents an analytical summary of
test performance and display the trade-off between sensitivity and
specificity. An AUC of 1.0 (100%) indicates perfect discriminatory
ability to distinguish cases from non cases. The Q* index, is the
highest point in the SROC curve that intersects the anti-diagonal
and represents a summary of test performance where sensitivity
and specificity are equal. A Q* index of 1.0 indicates 100% or
perfect accuracy (sensitivity and specificity of 100%). Both values
range between 0 to 1, and higher values indicate better test
performance [43,50,51].
Results
Study selection
The search of the selected databases retrieved 516 potentially
relevant references on diagnostic tests for H. pylori infection in
children. After screening titles and abstracts, 214 English and
Spanish articles were selected for full-text review, and 76 of them
met the eligibility criteria; from these articles ten were excluded
because data did not provide reliable information about sensitivity
and specificity; and other 28 articles were excluded due to lack of a
gold standard for diagnosing H. pylori infection. In the end, 38
articles (68 studies) met eligibility criteria and were included in the
meta-analysis [52–89]. Figure 1 shows the study selection process.
Characteristics of included studies
Of the 38 articles, 18 [52,53,56,58,59,61,62,67,69,71,73,74,76,
78,79,82,85,89] (47.5%) used culture and histological examination as
the gold standard; ten [54,60,64,70,72,80,81,83,84,87] (26.3%) used
histology in combination with RUT and UBT; two articles [63,68]
(5.2%) used histology alone and seven articles [55,57,66,75,77,86,88]
(18.4%) used UBT; and finally one article [65] (2.6%) used culture +
UBT as gold-standard. For all articles the ELISA and WB tests did
not form part of the reference standard. The median sample size of
the included studies was 110.5 (interquartile range 75.8 to 184).
Three papers in Spanish were included [62,64,76]. Thirty-one
(81.5%) articles reported using a case-control design and the
remaining seven [53,57,65,66,68,69,75] (18.5%) a cross-sectional
design. Thirty-two of the 38 (84.2%) articles collected samples
prospectivelyand six [53,65,66,69,74,85] (15.8%)retrospectively; two
[65,75] (5.2%) articles reported the use of a randomly selected subset
of the sample for validation with the reference standard. Eleven
[52,61,63,64,67,68,78–81,83] (28.9%) articles reported at leastsingle-
blinded interpretation of the ELISA and WB tests and reference
standard results, while 27 (71.1%) articles did not mention the
Figure 1. Study selection process and reasons for exclusion.
doi:10.1371/journal.pone.0003751.g001
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evaluation of more than one diagnostic test against the gold-standard;
in these cases each test comparison was counted as a separate study.
Thus, the total number of test comparisons (hereafter referred to as
studies) was 68. A total of 9,455 children were included in the meta-
analysis. Of these; 3,441 were H. pylori positive and 6,014 were H.
pylori negative according to the gold standard. Clinical specimens
evaluated included serum, urine, and saliva. For the meta-analysis the
serological antibody detection tests were divided into two groups:
ELISA and Western Blot. ELISA group was further sub-grouped by
type of sample: serum, urine, or saliva. The serum subgroup was
divided into IgG and IgA according to the immunoglobulin isotype
that was determined. Table 1 describes the characteristics of the 68
studies and the outcomes for the subgroups of diagnostic tests.
How accurate is ELISA for the diagnosis of H. pylori
infection in children?
Fifty-eight studies, involving a total of 8,336 children (2,742 H.
pylori positive and 5,594 H. pylori negative), assessed the diagnostic
accuracy of the ELISA test. Table 1 shows performance and other
characteristics for this group.
Serum. Forty two studies were included in the subgroup for
ELISA-IgG, of these, 33 (78.5%) studies assessed the performance
of 19 different commercial tests, and nine (21.4%) studies assessed
the performance of in-house test. These tests used different H.
pylori antigens, such as Whole Cell (WC), Urease, VacA, and CagA
recombinant protein. Regarding commercial tests, Cobas Core
EIAH (Roche, Mannheim, Germany) and FlexSureHHP Serum
Test (SmithKlineDiagnostics Palo Alto, CA, USA) were the tests
most frequently evaluated (Figure 2A y B). Four of the seven
studies included in the ELISA-IgA subgroup used in-house tests
(two of them used CagA or Urease recombinant protein as
antigen), and the other three used commercial tests. The ELISA-
IgG test subgroup included 4,781 children; a summary of the
accuracy measures of this test is shown in Table 2. Pooled
estimates of sensitivity, specificity, LR+,L R 2; were 79.2%,
92.4%, 10.2, and 0.19 respectively. The results of the serum
ELISA-IgG subgroup (42 studies) are shown in Figure 2A. In
general, specificity estimates were higher and more consistent
(range 78% to 100%) than sensitivity estimates (range 25% to
100%). The corresponding SROC (Figure 3) shows an area under
curve of 0.95 and a Q* of 0.89, indicating high overall accuracy.
The pooled DOR was 60.9 (95% CI, 41.8–88.6), but
heterogeneity across studies was significantly high (p,0.0001)
(Table 1). When compared with the ELISA-IgG subgroup, the
ELISA-IgA subgroup provided lower estimates for sensitivity,
specificity, LR+ and LR2 42.6%, 90.9%, 4.4, and 0.60
respectively. In addition, the accuracy (AUC=0.85 and
Q*=0.78) and DOR value 9.6 (95% CI 4.8–19.0) were lower
for ELISA-IgA than for ELISA-IgG, although in this case
heterogeneity was not significant (p=0.150) (Table 1).
Urine and Saliva. We assessed four studies in the urine
group and five in the saliva group, including 738 and 1,387
children respectively. Table 1 shows the performance and
characteristics of these studies; all of them evaluated commercial
tests and determined the IgG isotype. The antigen composition
was not described because it was considered proprietary
information. Summary measures of test accuracy for both
sample sources were: for the urine group sensitivity, specificity,
LR+ and LR2 were 59.1%, 92.9%, 9.6 and 0.23 respectively;
whereas for the saliva group values were 69.1%, 94.7%, 14.4 and
0.33 respectively. The sensitivity estimates were lower and more
variable than the specificity estimates in both sample groups
(Table 2). Furthermore this variation was more notable in the
urine group (range 30% to 94%) than in the saliva group (range
65% to 81%). However, the overall accuracy of the tests was
higher in the urine group AUC=0.94, and Q*=0.88 than in the
saliva with AUC=0.85, and Q*=0.78 indicating a modest
accuracy for the latter (Data not shown). The pooled DOR
value was similar for the two groups (urine: 44.2 [95% CI, 17.2–
113.9]; saliva 49.1 [95% CI, 22.6–106.8]). Only for the saliva
group, was significant heterogeneity present (p=0.012) (Table 1).
Table 1. Summary of characteristics of the studies included in the meta-analysis.
Diagnostic Test No Studies Sample Size (H. pylori+/2) Test Type DOR (95% CI)
*Test for
Heterogeneity
Serum
ELISA-IgG 42 1861/3771
+CK (33) 60.9 127.2 (,0.0001)
In-house (9) (41.8–88.6)
ELISA-IgA 7 250/329 CK (3) 9.6 9.4 (0.150)
In-house (4) (4.8–19.0)
Western-Blot 10 699/420 CK (8) 158.8 27.6 (0.001)
In-house (2) (57.8–435.8)
Urine
ELISA-IgG 4 301/437 CK (4) 44.2 5.9 (0.116)
(17.2–113.9)
Saliva
ELISA-IgG 5 330/1057 CK (5) 49.1 12.8 (0.012)
(22.6–106.8)
Total 68 3441/6014 ------ ------- ------
+CK=Commercial Kit.
*Chi-squared and p value.
doi:10.1371/journal.pone.0003751.t001
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pylori infection in children?
Ten studies were included in the Western Blot group involving
1,119 children between 1 and 16 years of age. Eight of the ten
studies used HelicoBlotH (Genelabs Diagnostics, Singapore), a
commercial test that is based on the analysis of whole-cell H. pylori
antigens. Currently, there are two presentations available: version
2.0 contains antigens of 19.5, 26.5, 30, 35, 89 (VacA), and 116
(CagA) kDa; and version 2.1 contains antigens of 19.5, 30, 35, 37,
89 (VacA), and 116 (CagA) kDa, the latter version also contains an
additional recombinant antigen (,45 kDa) named the current
infection marker (CIM). This protein was constructed by immuno-
logical screening of a genomic DNA library of H. pylori (ATCC
strain 43526) [90]. Four studies used HelicoBlot version 2.0, four
used version 2.1, and two evaluated the performance of in-house
Western blot test (Figure 4A and B). Summarized accuracy
measures are shown in Table 2. Pooled estimates of sensitivity,
specificity, LR+,L R 2; were 91.3%, 89.0%, 8.2, and 0.06
respectively. The sensitivity and specificity estimates were similar
in range and varied between 69 to 100% for sensitivity and
between 68 to 100% for specificity (Figure 4A). Figure 5, shows the
corresponding SROC curve; the area under the curve was 0.96
and the Q* was 0.91, indicating a high overall accuracy. In
addition, the studies that evaluated Western Blot test had a high
DOR value 158.8 (95% CI, 57.8–435.8), nevertheless heteroge-
neity was significant (p=0.001) (Table 1).
Possible reasons for the observed heterogeneity
In order to identify factors associated with the considerable
heterogeneity observed in the serum ELISA-IgG group, we
Figure 2. Forest Plot for the Sensitivity and Specificity of the Serum IgG-ELISA Diagnostic Tests. The squares and lines represent the
point estimates and 95% CIs, respectively. The size of square indicates the study size. The pooled estimated is denoted by a diamond at the bottom.
a=Enzygnost II, b=Pyloritest, c=MedMira; d=FlexSure, e=Eurospital, f=Eurospital-CagA, g=Cobas II, h=HM-CAP, i=In-house WC, j=In-house Urease,
k=In-house CagA, l=GAP-Test, m=HEL-p II, n=Cobas I, o=InmunoLISA, p=Helico-G, q=Pyloriset, r=Helory, s=Platelia, t=Immulite, u=PyloriStat,
v=GAP-Biomerica
doi:10.1371/journal.pone.0003751.g002
Table 2. Summary measures of test accuracy from the studies included.
Diagnostic Test Sensitivity Specificity LR+ LR2
(95% CI) (95% CI) (95% CI) (95% CI)
Serum
ELISA-IgG 79.2 (77.3–81.0) 92.4 (91.6–93.3) 10.2 (8.1–13.0) 0.19 (0.15–0.25)
ELISA-IgA 42.6 (36.4–49.0) 90.9 (87.2–93.8) 4.4 (2.7–7.1) 0.60 (0.45–0.79)
Western-Blot 91.3 (88.9–93.3) 89.0 (85.7–91.9) 8.2 (5.1–13.3) 0.06 (0.02–0.16)
Urine
ELISA-IgG 59.1 (53.3–64.7) 92.9 (90.1–95.1) 9.6 (3.9–23.4) 0.23 (0.08–0.68)
Saliva
ELISA-IgG 69.1 (63.8–74.1) 94.7 (93.2–96.0) 14.4 (7.3–28.6) 0.33 (0.28–0.39)
LR+=Likelihood positive.
LR2=Likelihood negative.
CI=Confidence Intervals.
doi:10.1371/journal.pone.0003751.t002
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and in-house (9 studies) tests and compared their performance.
Since there was a large number (19 tests) of different commercial
tests evaluated in this review, greater heterogeneity was expected.
In-house tests showed high overall performance with pooled
estimates of sensitivity 88.4%, specificity 96.6%, LR+ 19.7, and
LR2 0.10. Also, when we performed the analysis only with whole-
cell antigen for the in-house test the overall performance was
better with pooled estimates of sensitivity 94%, specificity 96.4%,
LR+ 19.9, and LR2 0.08 as compared with the estimates for the
commercial tests 77.7%, 91.8%, 9.2, and 0.22 respectively. Again,
the overall accuracy of the in-house tests with whole-cell antigen
was higher (AUC=0.98 and Q*=0.94.2) than that of the
commercial tests (AUC=0.94 and Q*=0.88) (Figure 6). Further-
more, heterogeneity prevailed only in the commercial test group,
DOR value was 46.9 (95% CI, 32.4–67.9) and heterogeneity was
significant (p,0.0001). In contrast, in-house test had higher DOR
value 224.8 (95% CI; 87.5–577.5); and in-house ELISA with using
exclusively whole-cell antigen had the highest DOR value 292.8
(95% CI; 101.8–841.7); in both cases a non-significant heteroge-
neity was documented (p=0.119).
Discussion
Principal findings
Our comprehensive literature search identified 68 studies that
addressed performance of tests for the diagnosis of H. pylori infection
in children.The results of the meta-analysis suggest that (1) WB tests
show high overall performance with sensitivity of 91.3%, specificity
of 89%, reasonably high LR+ (8.2) and very low LR2 (0.06),
suggesting WB is the most reliable test for the diagnosis of H. pylori
infection in children; (2) ELISA-IgG assays provide low sensitivity
(79.2%) and high specificity (92.4%); (3) ELISA commercial tests
vary widely in performance (test for heterogeneity p,0.0001); and
(4) In-house ELISA withwhole-cell antigen tests have high accuracy
(sensitivity 94% and specificity 96.4%). This is also reflected in the
high LR+ estimate (19.9) and low LR2 estimate (0.08), suggesting
that these tests have a potential role in ruling out or confirming H.
pylori infection in children.
Potential explanations for the lower specificity of WB-based tests
include the following: a) the occurrence of transient H. pylori
Figure 4. Forest Plot for the Sensitivity and Specificity of the
Western Blot Diagnostic Tests. The squares and lines represent the
point estimates and 95%CIs, respectively. The size of square indicates
the study size. The pooled estimated is denoted by a diamond at the
bottom. a=HelicoBlot 2.0, b=HelicoBlot 2.1, c=HelicoBlot 2.1 CIM; d=In-
house
doi:10.1371/journal.pone.0003751.g004
Figure 5. Summary Receiver Operator Curve (SROC) for
Western Blot Diagnostic Tests. Each solid square represents an
individual study in the meta-analysis. The curve is the regression line
that summarizes the overall diagnostic accuracy. AUC=area under
curve, SE (AUC)=standard error of AUC, Q*=index defined by point of
the SROC curve where the sensitivity and specificity are equal; SE
(Q*)=standard error of Q* index.
doi:10.1371/journal.pone.0003751.g005
Figure 3. Summary Receiver Operator Curve (SROC) for Serum IgG-ELISA Diagnostic Tests. Each solid square represents an individual
study in the meta-analysis. The curve is the regression line that summarizes the overall diagnostic accuracy. AUC=area under curve, SE
(AUC)=standard error of AUC, Q*=index defined by point of the SROC curve where the sensitivity and specificity are equal; SE (Q*)=standard error
of Q* index.
doi:10.1371/journal.pone.0003751.g003
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reported as a common phenomenon in children. This observation
may explain the incidence of false positive results since antibody
titers decrease slowly after clearance of infection [24,91,92]; b)
immunological cross-reaction, as the flagellar complex protein has
shown antigenic similarity with spiral-shaped bacteria colonizing
the intestinal mucus, such as C. jejuni [93,94], and c) variable
criteria for results interpretation, stemming from different
published recommendations which have resulted in considerable
confusion regarding interpretation criteria [95–98]. For example,
one interpretation system used a quantitative cutoff value to assess
band intensity [98], while other systems considered any band
intensity as a positive result [96,97]. Several interpretation systems
do not use criteria for low molecular weight and weak bands,
which represent the two components of the flagellar complex (55
and 59 kDa) [95,98]. An LR+ of 8.2 for WB-based tests provides
moderate evidence that children with H. pylori infection have a
greater chance of being WB test positive, compared with children
without the infection. This ratio is a reasonable guide enabling the
clinician to rule in (e.g. confirm) infection [99]. Also, an LR2 of
0.06 provides strong evidence to exclude H. pylori infection when a
child’s WB test result is negative. This result is important since it
guides the clinician to refrain from unnecessary and potentially
harmful treatments of children who are not actually infected.
It is generally accepted that H. pylori infection is acquired in
childhood or adolescence, and that early acquisition of this
infection could increase the risk of H. pylori-related complications
later in life; in fact it has been proposed that earlier infection is
linked to a greater risk for gastric cancer [3,4,8]. These risks for
disease during adulthood are good reason to have an accurate
diagnosis of H. pylori infection in childhood. Although a number of
authors have studied the antibody response against H. pylori in
children, the results reported have been variable, which may be
explained partially by the variation in prevalence across
populations and age-groups [1,2,6–8]. Still, in many instances
the variability of results may also be due to differences in the
characteristics of the diagnostic tests used.
Regarding ELISA for the diagnosis of H. pylori in serum, urine
and saliva from children, our results suggest that detection of IgG
antibodies in serum is acceptable, with high specificity 92.4% and
LR+ of 10.2 indicating that children with H. pylori infection have
10.2 fold higher chance of being ELISA-IgG test positive
compared with non-infected children. The summary estimate for
sensitivity, however, was lower 79.2%, and more variable than the
specificity estimate. Furthermore, antibody detection in urine and
saliva samples yielded the lowest sensitivities, 59.1% and 69.1%,
respectively, suggesting that these tests did not perform well in
children. The corresponding LR2 ratios, (urine, 0.23 and saliva
0.33) suggest that infection cannot be excluded when test results
are negative. The amount of antibodies in urine and saliva
probably correlates with the amount of antibodies present in
serum, but at a lower concentration, possibly explaining why these
samples provided lower sensitivities than serology. The low
sensitivity in antibody detection by ELISA may also be explained
by: a) age. Our meta-analysis included children with a wide range
of ages (,1 to 19 years). The ability to mount an efficient immune
response varies with age, showing a weaker response during the
first years of life [10,13,14,78]; b) ethnic groups. Different H. pylori
strains and even different antigens of the same strain show diverse
antigenicity among ethnic groups and geographical areas.
Sequence heterogeneity in protein-encoding genes may result in
variation of immunogenic epitopes [29,33,100]; c) specimen
handling. The majority of studies used frozen sera; thus samples
from different studies were subjected to diverse freeze-thaw cycle
histories which may affect sensitivity [27,30]; d) reference
standard. Although culture and histology are considered gold
standards for diagnosing H. pylori infection, these tests are not
100% accurate [10,11] and endoscopy is not suitable for children.
On the other hand, UBT has sensitivity and specificity
approaching 100%, making it an appropriate noninvasive
reference standard in children; thus, we included studies that
relied on culture, histology and/or UBT to confirm H. pylori
infection; and e) composition of the antigens included in
commercial tests. In most cases antigen identity was unknown as
this was considered proprietary information. Even after adjust-
ments in a regression analysis no single component accounted for
the wide variability observed (data not shown). Thus, ELISA tests
in children showed high specificity and LR+ values, but low
Figure 6. Summary Receiver Operator Curves (SROC) for commercial and in-house tests from Serum IgG-ELISA. Each solid square
represents an individual study in the meta-analysis. The curve is the regression line that summarizes the overall diagnostic accuracy. AUC=area under
curve, SE (AUC)=standard error of AUC, Q*=index defined by point of the SROC curve where the sensitivity and specificity are equal; SE
(Q*)=standard error of Q* index.
doi:10.1371/journal.pone.0003751.g006
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clinical implications, since a negative test would not be reliable for
ensuring the absence of H. pylori infection. In other words, patients
with negative ELISA results would present a fairly high chance of
actually having past or current infection. Low sensitivity may be
explained in part because of the weak or immature immune
response observed in young children.
Epidemiological and clinical implications
The interpretation of ELISA and WB tests in children depends
on the purpose of the examination. If antibody detection is to be
used for serologic-epidemiologic surveys, results suggest that both
tests are useful tools. When antibody detection is used for pre-
endoscopic screening, results suggest that a two-step serological
approach should be followed; first, a serum ELISA-IgG to identify
the majority of truly and potentially H. pylori-infected children and
second, a WB-test to reduce false-positive ELISA results and
eventually identify the specific antigens being recognized by the
antibodies. If the purpose of antibody detection is to decide whether
or not to treat H. pylori infection in children with severe dyspepsia or
chronic abdominal pain, results suggest that antibody detection
should not be used as the only justification for treatment. The
serological test should be confirmed by another diagnostic test, in
particular, histological examination or culture. In addition, the
European Task Force [101] and NASPGN [10] recommend that
screening of symptomatic children be performed by endoscopy to
obtaina more completedifferentialdiagnosis,e.g., pain,esophagitis,
peptic ulceration, gastritis and H. pylori infection. Current serologic
tests are not useful for monitoring eradication of infection after
therapy since they cannot distinguish between current or past H.
pylori infection, and the antibody titers usually remain positive
several months after the infection has been eradicated. Recently, a
new version of the commercial WB test, HelicoBlotH 2.1 (Genelabs
Diagnostics, Singapore) has been marketed which includes an
antigenic protein known as CIM (current infection marker).
According to the manufacturer, the detection of anti-CIM IgG is
highly predictive of active (current) H. pylori infection [83,102].
Further studies are needed to confirm these findings.
In summary, high accuracy is provided by in-house ELISA tests
for H. pylori infection in children. Advantages of ELISA are
simplicity, minimal patient discomfort and the rapidity by which
results can be obtained. On the other hand, also the WB test
achieved high accuracy. However, WB is not widely available,
perhaps due to its high cost, test handling requirements and
differences in result interpretation. The main advantage of WB
tests is the possibility of providing specific antigen profiles. Since
the initial antibody response in children is principally to small
molecular size antigens and, in chronic patients, to larger
molecular size antigens, WB tests also provide information about
the type of infecting strain as they can distinguish between CagA
or VacA strains.
Analysis of the heterogeneity
We investigated heterogeneity by stratifying the ELISA-IgG
subgroup into commercial and in-house tests. The shape of the
SROC curve (Figure 3) suggests that variability in the different
thresholds used among studies could partially explain the
heterogeneity [43,44,49]. The in-house tests showed higher
accuracy, the DOR estimate was about five times greater than
the value for commercial tests (224.8 vs 46.9); furthermore, with
whole cell antigen the in-house test was six time greater (292.8 vs
46.9). However, considerable heterogeneity persisted in the
commercial test group even after this stratification. The variability
in the ELISA protocols may in-part explain this result. For
example, within the commercial tests, 19 different protocols were
described, including FlexSureHHP Serum Test (SmithKline
Diagnostic, Palo Alto, CA, USA) and Pyloriset Screen (PS, Orion
Diagnostica, Espoo, Finland) which are rapid blood tests, and
others such as Cobas Core EIAH (Roche, Mannheim, Germany)
and Enzygnost IgG (Behring, Marburg, Germany) which are
based on conventional ELISA protocols. Heterogeneity could be
related to differences in antigen source, composition, or level of
purity. Diversity in the specificity of the immune response among
populations due to differences in the infecting strains is also
another factor that may explain variability. Yet another factor is
the diversity in the ages of the children involved; several
epidemiological studies have shown a significantly higher IgG
response to H. pylori in older children [9,10,14,31,62,78,81].
Different times for obtaining samples could also affect results.
Mitchel et al [14] have shown that in acutely infected children,
there is an initial antibody response to small molecular size
antigens and a later response to bigger proteins such as CagA; this
could partially explain the increase of the sensitivity of the in-house
test when using whole-cell as antigen versus recombinant proteins
such as CagA. This suggests that recently infected children have
not yet mounted an immune response to some H. pylori antigens.
Finally, the comparison of a test against an imperfect reference
standard could result in underestimation of test accuracy.
It is clear that there is a need to perform more studies with
commercial H. pylori ELISA tests controlling as much as possible
for all variables mentioned above, with a well designed and
properly controlled protocol. In our meta-analysis we excluded
studies with clinical data, but without standard confirmation
(called class three reference). In general, since the sensitivity and
specificity of ELISA test are widely variable, clinicians may have to
rely on data developed in their own institutions or country, to
produce clinically useful estimates of test accuracy, local
adjustments particularly in the source of the antigen, i.e. use of
whole-cell extracted from H. pylori strains isolated from the
community must be validated in the populations
[7,10,11,78,81,101].
Strengths and weaknesses of the review
An important strength of our study was its comprehensive
search strategy, though it is possible that we may have missed some
eligible studies. Screening, study selection and quality assessment
were done independently by two reviewers. For some studies, we
reduce the problem of missing data by contacting directly the
authors. We also explore heterogeneity and potential publication
bias in accordance with published guidelines. We analyzed data
within specific subgroups to lessen the effect of heterogeneity.
We recognized some limitations of our study; we were able to
include only English and Spanish language articles due to the
linguistic abilities of our team, and this could have introduced
selection bias to our results. Second, we did not address the effect of
factors such as laboratory infrastructure, expertise with the
technology test, and patient spectrum. Although, we used standard
guidelines for reporting diagnostic accuracy of tests (STARD) to
improve the quality of our analysis [46], our findings should be
interpreted in the context of the quality of reporting and variability
of the included studies. Unfortunately we were not able to evaluate
the ELISA performance among different ages, because this
informationwasnotavailableinthe majorityoftheincludedstudies.
In conclusion, the evidence provided in this meta-analysis
suggests that, at the current time, both WB test and in-house
ELISA with whole-cell antigen are the most reliable tests for the
diagnosis of H. pylori infection in children. Since the sensitivity and
specificity of commercial ELISA tests are widely variable,
H. pylori Diagnosis in Children
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institution or country to warrant clinically useful results In
particular, local adjustments in antigen source using H. pylori
strains isolated from the community and validated for the
population may be required.
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